Log in

Moderna Price Target, Predictions & Analyst Ratings

+17.85 (+16.35 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $127.03
50-Day Range
MA: $79.27
52-Week Range
Now: $127.03
Volume42.52 million shs
Average Volume16.67 million shs
Market Capitalization$50.27 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Moderna (NASDAQ:MRNA) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
19 Wall Street analysts have issued ratings and price targets for Moderna in the last 12 months. Their average twelve-month price target is $96.72, predicting that the stock has a possible downside of 23.86%. The high price target for MRNA is $166.00 and the low price target for MRNA is $24.00. There are currently 2 sell ratings, 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
MRNA Consensus Rating: BuyBuyBuyBuy
MRNA Consensus Rating Score: 2.582.762.822.92
MRNA Analyst Ratings: 2 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
MRNA Consensus Price Target: $96.72$87.41$88.53$77.50
MRNA Price Target Upside: 23.86% downside27.90% upside29.55% upside18.57% upside

Moderna (NASDAQ:MRNA) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Moderna (NASDAQ:MRNA) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/25/2020The Goldman Sachs GroupBoost Price Target$107.00 ➝ $139.00High
11/24/2020SVB LeerinkBoost Price TargetUnderperform$59.00 ➝ $60.00Low
11/23/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$92.00Low
11/17/2020Redburn PartnersInitiated CoverageSellMedium
11/17/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$109.00Medium
11/16/2020Chardan CapitalBoost Price TargetPositive ➝ Buy$93.00 ➝ $107.00High
11/16/2020OppenheimerBoost Price TargetOutperform$108.00 ➝ $157.00High
11/16/2020Piper SandlerBoost Price TargetOverweight$136.00 ➝ $166.00High
11/11/2020ArgusBoost Price TargetBuy$80.00 ➝ $88.00High
11/11/2020Morgan StanleyBoost Price TargetOverweight$90.00 ➝ $100.00High
8/12/2020Jefferies Financial GroupReiterated RatingBuy$90.00Medium
8/6/2020JPMorgan Chase & Co.Reiterated RatingHoldMedium
8/5/2020Needham & Company LLCInitiated CoverageBuy$94.00Medium
7/27/2020SunTrust BanksInitiated CoverageBuy$120.00High
7/13/2020Brookline Capital ManagementReiterated RatingBuy$95.00High
6/8/2020BarclaysInitiated CoverageOverweight$68.00N/A
6/3/2020Bank of AmericaLower Price Target$80.00 ➝ $75.00Medium
5/11/2020Roth CapitalBoost Price TargetBuy$41.00 ➝ $68.00N/A
1/2/2020Piper Jaffray CompaniesInitiated CoverageOverweight$24.00N/A
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.